• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症中痉挛、疼痛及阵发性现象的管理

Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis.

作者信息

Schapiro R T

机构信息

Department of Neurology, Fairview Multiple Sclerosis Center and University of Minnesota, 701 25th Ave. South, #200, Minneapolis, MN 55454, USA.

出版信息

Curr Neurol Neurosci Rep. 2001 May;1(3):299-302. doi: 10.1007/s11910-001-0034-6.

DOI:10.1007/s11910-001-0034-6
PMID:11898533
Abstract

Multiple sclerosis (MS) is a disease with tremendous variability and innumerable symptoms. Among the more common symptoms is spasticity. Despite a lack of full knowledge of the physiology causing this phenomenon, successful treatments have been developed. Many of these have had a recent introduction. Pain and paroxysmal phenomena are surprisingly common in MS, but have not had the recognition their frequency deserves. It is not unusual to hear that they are rare in MS, but surprisingly they are all too common. Their management is changing as newer treatments are developed.

摘要

多发性硬化症(MS)是一种具有极大变异性和无数症状的疾病。较为常见的症状之一是痉挛。尽管对导致这种现象的生理学机制尚未完全了解,但已经开发出了成功的治疗方法。其中许多方法是最近才引入的。疼痛和发作性现象在MS中出奇地常见,但它们的频发程度并未得到应有的认识。经常听到有人说这些症状在MS中很罕见,但令人惊讶的是,它们其实非常常见。随着新治疗方法的开发,它们的管理方式也在发生变化。

相似文献

1
Management of spasticity, pain, and paroxysmal phenomena in multiple sclerosis.多发性硬化症中痉挛、疼痛及阵发性现象的管理
Curr Neurol Neurosci Rep. 2001 May;1(3):299-302. doi: 10.1007/s11910-001-0034-6.
2
[Pharmacological treatment of spasticity in multiple sclerosis].[多发性硬化症痉挛的药物治疗]
Rev Neurol (Paris). 2012 Apr;168 Suppl 3:S62-8. doi: 10.1016/S0035-3787(12)70049-8.
3
Pharmacotherapy of spasticity: oral medications and intrathecal baclofen.痉挛的药物治疗:口服药物与鞘内注射巴氯芬
J Child Neurol. 2001 Jan;16(1):31-6. doi: 10.1177/088307380101600106.
4
Treatment of spasticity.
Spinal Cord. 2002 Jun;40(6):261-2. doi: 10.1038/sj.sc.3101313.
5
Antispasticity medications: uses and limitations of enteral therapy.
Am J Phys Med Rehabil. 2004 Oct;83(10 Suppl):S50-8. doi: 10.1097/01.phm.0000141132.48673.fa.
6
[Pharmacology of spasticity. Does therapy remain in deep sleep?].[痉挛的药理学。治疗是否仍处于深度睡眠状态?]
Nervenarzt. 2000 Dec;71(12):927-8. doi: 10.1007/s001150050688.
7
Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper.多发性硬化痉挛的药物治疗:系统评价和共识文件。
Mult Scler. 2016 Oct;22(11):1386-1396. doi: 10.1177/1352458516643600. Epub 2016 May 19.
8
Spasticity: revisiting the role and the individual value of several pharmacological treatments.痉挛:重新审视几种药物治疗的作用和个体价值。
NeuroRehabilitation. 2010;27(2):193-200. doi: 10.3233/NRE-2010-0596.
9
GABA agonists and gabapentin for spastic hypertonia.
Phys Med Rehabil Clin N Am. 2001 Nov;12(4):875-88, viii.
10
A mixed treatment comparison on efficacy and safety of treatments for spasticity caused by multiple sclerosis: a systematic review and network meta-analysis.多靶点治疗多发性硬化痉挛的疗效和安全性的混合治疗比较:系统评价和网络荟萃分析。
Clin Rehabil. 2018 Jun;32(6):713-721. doi: 10.1177/0269215517745348. Epub 2018 Mar 27.

引用本文的文献

1
A comprehensive two-sample Mendelian randomization analysis of trigeminal neuralgia and modifiable risk factors.三叉神经痛与可改变风险因素的综合两样本孟德尔随机化分析。
Front Neurol. 2023 Nov 22;14:1292958. doi: 10.3389/fneur.2023.1292958. eCollection 2023.
2
Mechanisms of action of ACTH in the management of relapsing forms of multiple sclerosis.促肾上腺皮质激素(ACTH)在复发型多发性硬化症治疗中的作用机制。
Ther Adv Neurol Disord. 2014 Mar;7(2):83-96. doi: 10.1177/1756285613518599.
3
Current management of pain associated with multiple sclerosis.

本文引用的文献

1
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.卡立普多治疗多发性硬化症的初步试验
Practitioner. 1964 Apr;192:540-2.
2
Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study.肉毒杆菌毒素(Dysport)治疗多发性硬化症患者髋内收肌痉挛:一项前瞻性、随机、双盲、安慰剂对照、剂量范围研究。
J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):707-12. doi: 10.1136/jnnp.68.6.707.
3
Amantadine is beneficial in restless legs syndrome.金刚烷胺对不宁腿综合征有益。
多发性硬化症相关疼痛的当前管理方法。
CNS Drugs. 2008;22(4):291-324. doi: 10.2165/00023210-200822040-00003.
4
A benefit-risk assessment of baclofen in severe spinal spasticity.巴氯芬用于严重脊髓痉挛的获益-风险评估
Drug Saf. 2004;27(11):799-818. doi: 10.2165/00002018-200427110-00004.
Mov Disord. 2000 Mar;15(2):324-7. doi: 10.1002/1531-8257(200003)15:2<324::aid-mds1020>3.0.co;2-4.
4
Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial.加巴喷丁对多发性硬化症痉挛的影响:一项安慰剂对照的随机试验。
Arch Phys Med Rehabil. 2000 Feb;81(2):164-9. doi: 10.1016/s0003-9993(00)90135-7.
5
Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis.三叉神经痛的微血管减压术:对250例病例的评论,包括10例多发性硬化症患者。
J Neurol Neurosurg Psychiatry. 2000 Jan;68(1):59-64. doi: 10.1136/jnnp.68.1.59.
6
Cannabis and cannabinoids: pharmacology and rationale for clinical use.大麻与大麻素:药理学及临床应用原理
Forsch Komplementarmed. 1999 Oct;6 Suppl 3:12-5. doi: 10.1159/000057150.
7
Treatment of periodic leg movements with a dopaminergic agonist in subjects with total spinal cord lesions.多巴胺能激动剂治疗完全性脊髓损伤患者的周期性腿部运动。
Spinal Cord. 1999 Sep;37(9):634-7. doi: 10.1038/sj.sc.3100909.
8
Pharmacology of cannabinoid receptor ligands.大麻素受体配体的药理学
Curr Med Chem. 1999 Aug;6(8):635-64.
9
Quantitative analysis of the pendulum test: application to multiple sclerosis patients treated with botulinum toxin.
Funct Neurol. 1999 Apr-Jun;14(2):79-92.
10
Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine.多发性硬化症的阳性症状:用钠通道阻滞剂、利多卡因和美西律进行治疗。
J Neurol Sci. 1999 Jan 15;162(2):162-8. doi: 10.1016/s0022-510x(98)00322-0.